IP Library Granted Patent US 8,613,285
Granted Patent B2
US 8,613,285 · App. 12/757,936 · Granted Dec 24, 2013

Extrudable and extruded compositions for delivery of bioactive agents, method of making same and method of using same

Inventor: Richard C. Fuisz (Beverly Hills, CA)
Assignee: Philip Morris Products S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,613,285
App. No.
12/757,936
Granted
Dec 24, 2013
Kind
B2
Abstract

A nonaqueous, extrudable composition includes at least one thermoplastic polymer in an amount of more than 20 wt % of the whole composition and tobacco. An extruded bioactive product in the form of a sheet can be made by extruding or hot melt shaping a nonaqueous composition comprising at least one thermoplastic polymer and a bioactive agent, the sheet being soluble in a user's mouth and resulting in sustained release of bioactive to the user. The sheet can be in a form that may be placed in contact with the mucosa of the user, and have an average dissolution time of 5 to 50 minutes for delivering the bioactive to the user.

Claims (20)

1. An extruded bioactive product comprising a sheet made by extruding or hot melt shaping a nonaqueous composition comprising at least one thermoplastic polymer, an ion exchange resin and a bioactive agent other than tobacco, the composition not containing polycarbophil, the sheet comprising a matrix comprising the at least one thermoplastic polymer and an ion exchange resin and bioactive agent complex distributed in the matrix, the matrix being soluble in the mucosa of a user and resulting in sustained release of the bioactive agent to the user.

2. The extruded bioactive product according to claim 1 , wherein the sheet has a rectangular shape.

3. The extruded bioactive product according to claim 1 , wherein the at least one polymer comprises hydroxypropyl cellulose (HPC).

4. The extruded bioactive product according to claim 1 , wherein the bioactive is in the form of a nonaqueous liquid.

5. The extruded bioactive product according to claim 1 , further comprising a mucosal absorbing enhancer.

6. The extruded bioactive product according to claim 5 , wherein the sheet has an average dissolution time of 5 to 50 minutes and a thickness of approximately 10-50 mil, to dissolve in the oral cavity.

7. The extruded bioactive product according to claim 1 , further comprising a buffering agent for controlling a pH of the composition.

8. The extruded bioactive product according to claim 7 , wherein the buffering agent is present in an amount to provide the product with a pH of 2.5 to 9 when the composition is present in the user's mouth.

9. The extruded bioactive product according to claim 1 , wherein the bonds between the bioactive agent and the ion exchange resin are substantially intact.

10. The extruded bioactive product according to claim 1 , wherein the ratio of ion exchange to bioactive agent exceeds 3 to 1 (wt/wt).

11. The extruded bioactive product according to claim 1 , wherein the bioactive product is in the form of a sheet having a thickness greater than 10 mil.

12. The extruded bioactive product according to claim 1 , wherein the bioactive agent includes chitosan.

13. The extruded bioactive product according to claim 1 , wherein the extruded composition includes less than 6 wt % water.

14. The extruded bioactive product according to claim 1 , further comprising a flavoring.

15. The extruded bioactive product according to claim 1 , further comprising a plasticizer.

16. The extruded bioactive product according to claim 1 , wherein the sheet has a tensile strength of at least 4 lbs.

17. The extruded bioactive product according to claim 1 , wherein the sheet has a uniformity in the range of +−10%.

18. The extruded bioactive product according to claim 1 , wherein the at least one thermoplastic polymer is contained in an amount of at least 20 wt % of the whole composition.

19. The extruded bioactive product according to claim 1 , wherein the at least one thermoplastic polymer comprises a water soluble polymer.

20. The extruded bioactive product according to claim 1 , wherein the bioactive includes nicotine.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2010
From: FUISZ, RICHARD C.
To: FUISZ LLC
Reel/Frame 024277/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2010
From: FUISZ LLC
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 024279/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2010
From: FUISZ, RICHARD C.
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 024279/0157 →
Priority Claims (1)
WO PCT/US2008/011374 · Oct 2, 2008 · international
Continuity (6)
Continuation 12122201 · May 16, 2008
Continuation PCTUS2008011634 · Oct 10, 2008
Provisional Application 60979169 · Oct 11, 2007
Provisional Application 60990381 · Nov 27, 2007
Provisional Application 61054195 · May 19, 2008
Related Publication 20100247612A1 · Sep 30, 2010